Gennova Biopharmaceuticals, a Pune-based company which is making India's first mRNA vaccine, has submitted phase-2 trial data of its mRNA Covid-19 vaccine. The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will review the data soon.

Sources said the company has also developed an Omicron-specific vaccine, which will be tested on humans for efficacy & immunogenicity soon.

During his speech at the 76th United Nations General Assembly (UNGA), Prime Minister Narendra Modi had earlier stated that India’s first mRNA vaccine was in the final stages.

Leave a Reply